Cargando…
Arrhythmogenic substrate elimination for safe testosterone therapy in symptomatic Brugada syndrome patients
BACKGROUND: Brugada Syndrome (BrS) is a cardiogenetic disease known for its association with sudden cardiac death (SCD) in individuals with structurally normal hearts. The prevalence of BrS is higher in males, who also face a greater risk of SCD. Its higher prevalence and worse outcome in male subje...
Autores principales: | Negro, Gabriele, Boccellino, Antonio, Napolano, Antonio, Micaglio, Emanuele, Calovic, Zarko, Anastasia, Luigi, Ciconte, Giuseppe |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10472325/ https://www.ncbi.nlm.nih.gov/pubmed/37655650 http://dx.doi.org/10.1093/europace/euad254 |
Ejemplares similares
-
Electrocardiographic temporo-spatial assessment of depolarization and repolarization changes after epicardial arrhythmogenic substrate ablation in Brugada syndrome
por: Locati, Emanuela T, et al.
Publicado: (2023) -
Right ventricular epicardial arrhythmogenic substrate in long-QT syndrome patients at risk of sudden death
por: Pappone, Carlo, et al.
Publicado: (2023) -
Brugada syndrome genetics is associated with phenotype severity
por: Ciconte, Giuseppe, et al.
Publicado: (2020) -
Brugada Syndrome: Oligogenic or Mendelian Disease?
por: Monasky, Michelle M., et al.
Publicado: (2020) -
Brugada Syndrome: Warning of a Systemic Condition?
por: D'Imperio, Sara, et al.
Publicado: (2021)